Derek M Meisner, the Chief Legal Officer & Corp Sec of $ABOS, sold 15,085 shares of the company on 01-26-2026 for an estimated $45,262. We received data on the trade from a recent SEC filing. This was a sale of approximately 8.0% of their shares of this class of stock. Following this trade, they now own 173,999 shares of this class of $ABOS stock.
$ABOS Insider Trading Activity
$ABOS insiders have traded $ABOS stock on the open market 42 times in the past 6 months. Of those trades, 0 have been purchases and 42 have been sales.
Here’s a breakdown of recent trading of $ABOS stock by insiders over the last 6 months:
- DEREK M MEISNER (Chief Legal Officer & Corp Sec) has made 0 purchases and 14 sales selling 104,017 shares for an estimated $213,763.
- DANIEL JOSEPH OCONNELL (Chief Executive Officer) has made 0 purchases and 8 sales selling 86,013 shares for an estimated $163,123.
- MATT ZUGA (CFO & Chief Business Officer) has made 0 purchases and 7 sales selling 25,953 shares for an estimated $49,555.
- RUSSELL BARTON (Chief Operating Officer) has made 0 purchases and 6 sales selling 15,625 shares for an estimated $29,917.
- ERIC SIEMERS (Chief Medical Officer) has made 0 purchases and 4 sales selling 14,060 shares for an estimated $27,110.
- JAMES J. DOHERTY (President and CDO) has made 0 purchases and 2 sales selling 8,167 shares for an estimated $15,148.
- AMY SCHACTERLE (Chief Regulatory Officer) sold 1,097 shares for an estimated $2,176
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABOS Hedge Fund Activity
We have seen 21 institutional investors add shares of $ABOS stock to their portfolio, and 42 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 1,348,404 shares (-69.1%) from their portfolio in Q3 2025, for an estimated $2,305,770
- FRANKLIN RESOURCES INC removed 771,943 shares (-25.1%) from their portfolio in Q3 2025, for an estimated $1,320,022
- CITADEL ADVISORS LLC added 494,108 shares (+inf%) to their portfolio in Q3 2025, for an estimated $844,924
- RENAISSANCE TECHNOLOGIES LLC added 337,704 shares (+137.0%) to their portfolio in Q3 2025, for an estimated $577,473
- Y-INTERCEPT (HONG KONG) LTD removed 250,848 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $428,950
- PATHSTONE HOLDINGS, LLC removed 199,421 shares (-18.8%) from their portfolio in Q3 2025, for an estimated $341,009
- GOLDMAN SACHS GROUP INC removed 187,535 shares (-56.0%) from their portfolio in Q3 2025, for an estimated $320,684
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABOS Analyst Ratings
Wall Street analysts have issued reports on $ABOS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 11/18/2025
To track analyst ratings and price targets for $ABOS, check out Quiver Quantitative's $ABOS forecast page.
$ABOS Price Targets
Multiple analysts have issued price targets for $ABOS recently. We have seen 2 analysts offer price targets for $ABOS in the last 6 months, with a median target of $7.5.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $7.0 on 01/27/2026
- Geoff Meacham from B of A Securities set a target price of $8.0 on 11/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
